Pleural malignancy commonly leads to troublesome and recurrent effusio
n. Cure is not possible and effective palliation is important for the
2-3 months median survival following diagnosis. We have previously emp
hasised the role of pleuro-peritoneal shunts (PPS) in this situation.
A number of shunts (11%) malfunction and we have revised our policy as
to how best to deal with this problem. We studied our 70 patients who
required the insertion of 71 PPS over seven years: there were 8 cases
(11%) of non-functioning shunts necessitating re-exploration. In two
cases the shunt was blocked due to infection which may have been prese
nt prior to insertion of the shunt. In these cases the shunt was remov
ed and drainage was performed. In one shunt nonfunction was due to obs
truction of the pleural limb and it was re-positioned successfully. Th
e remaining five shunts were found to be blocked by fibrinous tissue.
Replacement of two of these led to a functioning shunt until the death
of the patients, while the three shunts which were revised failed to
function. One shunt became infected and was removed and the other two
became blocked again. Following subsequent replacement the function wa
s restored until the death of the two patients. We conclude that non-f
unctioning pleuro-peritoneal shunts should be replaced rather than rev
ised to avoid subsequent complications.